email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1921 - 1935
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
BeyondSpring Starts Rolling Application of China NDA for Neutropenia Treatment
$5.00
Available
Chi-Med Starts Phase II Trial of FGFR Inhibitor in Mesothelioma Patients
$5.00
Available
GoBroad Healthcare, a Hillhouse Company, Starts Construction of Beijing Research Hospital
$5.00
Available
Alphamab and 3D Medicines Choose Simcere to Market Their PD-L1 Candidate
$5.00
Available
Shenzhen's BGI Genomics Approved to Launch SARS-CoV-2 Test in the US
$5.00
Available
Fosun Long March's COVID-19 Test Approved in China
$5.00
Available
CStone Files Taiwan NDA for Precision-Med GIST Candidate
$5.00
Available
China's Asieris Pharma Lands $14 Million for Genito-Urinary Tumor Treatments
$5.00
Available
Innovent Acquires China Rights to Novel Immunoncology Candidate from Alector
$5.00
Available
Abbisko of Shanghai Raises $70 Million for Novel Oncology-Immunocology Candidates
$5.00
Available
Apexigen Adds $65 Million to C Round in Funding Led by China Investors
$5.00
Available
Mabpharm Out-Licenses US-EU Rights for COVID-19 Fusion Protein to Sorrento
$5.00
Available
Junshi Bio Teams Up with IMCAS to Develop Neutralizing Antibodies for COVID-19
$5.00
Available
Laekna Acquires Global Rights to Novartis Clinical-Stage PD-L1
$5.00
Available
Clover to Add Dynavax's Adjuvant to its COVID-19 Vaccine Candidate
$5.00
Available